4-168358152-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001012967.3(DDX60L):c.5116G>A(p.Glu1706Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,608,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001012967.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDX60L | NM_001012967.3 | c.5116G>A | p.Glu1706Lys | missense_variant | 38/38 | ENST00000682922.1 | NP_001012985.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDX60L | ENST00000682922.1 | c.5116G>A | p.Glu1706Lys | missense_variant | 38/38 | NM_001012967.3 | ENSP00000507872 | |||
DDX60L | ENST00000511577.5 | c.5116G>A | p.Glu1706Lys | missense_variant | 38/38 | 5 | ENSP00000422423 | P1 | ||
DDX60L | ENST00000510590.1 | n.2092G>A | non_coding_transcript_exon_variant | 9/9 | 2 | |||||
DDX60L | ENST00000513103.1 | n.416G>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000277 AC: 68AN: 245606Hom.: 0 AF XY: 0.000248 AC XY: 33AN XY: 133216
GnomAD4 exome AF: 0.000126 AC: 184AN: 1456128Hom.: 0 Cov.: 29 AF XY: 0.000115 AC XY: 83AN XY: 724456
GnomAD4 genome AF: 0.000138 AC: 21AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74306
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at